FDA Drug recall D-0656-2018
MVI-7 (B1-100mg/B3-100mg, B5-252 mg, B6-102mg, Vit C-2500 mg, B12-10mg, Mag-1000 mg)/ vial liquid injectable, 50 mL amber vial, Rx only, Pa…
- FDA Drug
- Class II
- terminated
- Published 2018-04-25
On 2018-04-25 the FDA classified a Class II recall of MVI-7 (B1-100mg/B3-100mg, B5-252 mg, B6-102mg, Vit C-2500 mg, B12-10mg, Mag-1000 mg)/ vial liquid injectable, 50 mL amber vial, Rx only, Pa… by Partell Specialty Pharmacy, citing lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0656-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-03-22 |
| Published | 2018-04-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Partell Specialty Pharmacy |
| Distribution | NV |
Product
MVI-7 (B1-100mg/B3-100mg, B5-252 mg, B6-102mg, Vit C-2500 mg, B12-10mg, Mag-1000 mg)/ vial liquid injectable, 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
Reason
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Identifiers
| code_info | Lot #: 20180223@1, BUD 04/24/2018; 20180129@5, BUD 03/30/2018; 20180126@4, BUD 03/27/2018; 20180215@22, BUD 04/16/2018;…Lot #: 20180223@1, BUD 04/24/2018; 20180129@5, BUD 03/30/2018; 20180126@4, BUD 03/27/2018; 20180215@22, BUD 04/16/2018; 20180122@10, 20180126@4, BUD 03/23/2018; 20180202@27, BUD 04/03/2018; 20180208@5, 20180201@2, BUD 04/02/2018; # 20180207@2, BUD 04/08/2018, 20180214@11, BUD 04/15/2018; 20180215@22, BUD 04/16/2018. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0656-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.